Repare Therapeutics Inc (RPTX) — Strategic Asset Allocation Index
Repare Therapeutics Inc (RPTX) has a Strategic Asset Allocation Index of 1.5% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $1.72 Million) total $1.72 Million, measured against net assets of $115.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See RPTX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Repare Therapeutics Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Repare Therapeutics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2025, the index stands at 1.5%, representing strategic assets of $1.72 Million against net assets of $115.13 Million USD. For live market cap and overall valuation, see RPTX stock market capitalisation.
Annual Strategic Asset Allocation Index for Repare Therapeutics Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Repare Therapeutics Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See RPTX net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.4% | $9.60 Million | $9.60 Million | $- | $279.52 Million | ▲ +1.5 pp |
| 2021 | 1.9% | $5.60 Million | $5.60 Million | $- | $288.42 Million | ▼ -1.1 pp |
| 2020 | 3.0% | $8.62 Million | $8.62 Million | $- | $286.83 Million | ▼ -0.8 pp |
| 2019 | 3.8% | $3.42 Million | $3.42 Million | $- | $89.87 Million | — |